Clinical recruitment (Research Unit: Xiangya Hospital Central South University)
Dear Patients:
Our hospital's Pancreatic Center is currently conducting a "single-arm, open-label clinical study evaluating the efficacy and safety of VRT106 biotherapy combined with chemotherapy for the treatment of resectable pancreatic cancer." This study has been approved by the hospital's ethics committee and is currently recruiting participants.
VRT106 exerts its anti-tumor effect through direct oncolytic effects and immune-mediated cytotoxicity. VRT106 has the characteristic of selectively targeting and killing solid tumors. The primary objective of this clinical study is to evaluate the efficacy, safety, and tolerability of VRT106 combined with gemcitabine and capecitabine for adjuvant therapy after pancreatic cancer surgery.
If you meet the following criteria:
1. Aged 18-75 years (inclusive), male or female;
2. Clinically diagnosed with pancreatic cancer;
3. Resectable pancreatic cancer as assessed by a professional surgeon, with clinical staging based on imaging assessment as: T1-3, N any, M0;
4. Able to start adjuvant therapy no later than 12 weeks after surgery; optional adjuvant chemotherapy regimens include gemcitabine and capecitabine.
5. No serious hematological, hepatic, renal, coagulation, or cardiac dysfunction;
If you are interested in participating in this study, please consult Professor Chen Rufu at Guangdong Provincial People's Hospital.
You can contact the following research doctors. He/she will provide a detailed explanation of the study and arrange for you to undergo relevant routine laboratory tests. If you meet the criteria after screening and enter the study, the center will provide the research treatment medication and related examinations. You and your family are welcome to consult the research doctor for details of this treatment method.
Contact Person | Contact Information |
| Dr. Zhou | 18665550915 |
| Dr. Luo | 15915982918 |
| Dr. Sun | 15603006776 |
Focus on us
Contact Information
Monday to Friday 9:00~17:00
Rooms 801-808 and 901-908, Building H, No. 3 Jiu Quan Road, Huangpu District, Guangzhou City
Copyright©2024 Virotech Pharmaceutical Technology Co., Ltd.
